Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: cytotoxic antibodies

Innate Pharma – therapeutic antibodies

Posted on by

Innate Pharma is a biopharma company developing therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Innate Pharma – therapeutic antibodies

innate pharma
Continue reading →

Posted in Biotech Companies, Biotech Companies France | Tagged ADC, ADCs, Alessandro Moretta, antibody drug conjugates, bacterial transglutaminase, Bernard MALISSEN, BTG, cancer, Catherine MOUKHEIBIR, chronic inflammatory diseases, cytotoxic antibodies, cytotoxic antibody, David RAULET, Eric Vivier, François Romagné, Gilles BRISSON, Hervé Brailly, immune cells, immune oncology, immuno-oncology, immunomodulating antibodies, immunomodulating antibody, inflammatory disease, inflammatory diseases, innate immunity, innate immunity cells, Innate Pharma, Innate Pharma - therapeutic antibodies, Irina STAATZ-GRANZER, Jean-Jacques Fournié, Jérôme TIOLLIER, Karsten Munk KNUDSEN, Marc Bonneville, Marcel ROZENCWEIG, Michael CALIGIURI, monoclonal antibodies, monoclonal antibody, Nicolai WAGTMANN, Patrick LANGLOIS, pharmacodynamics, pharmacotoxicology, Philip GREENBERG, Philippe POULETTY, Pierre DODION, Ron LEVY, therapeutic antibodies, therapeutic antibody, transglutaminase, Véronique CHABERNAUD, Yannis MOREL

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress